FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

34819011000001103: Ponatinib 30mg tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 08-Nov 2017. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
105502201000001119 Ponatinib 30mg tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
105502301000001111 Ponatinib 30mg tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ponatinib 30mg tablets Is a Ponatinib true Inferred relationship Existential restriction modifier
Ponatinib 30mg tablets Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Ponatinib 30mg tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ponatinib 30mg tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Oral route true Inferred relationship Existential restriction modifier
Ponatinib 30mg tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route tablet.oral ontology form and route true Inferred relationship Existential restriction modifier
Ponatinib 30mg tablets Plays role Antineoplastic therapeutic role true Inferred relationship Existential restriction modifier
Ponatinib 30mg tablets Is a Product containing ponatinib false Inferred relationship Existential restriction modifier
Ponatinib 30mg tablets Has active ingredient Ponatinib false Inferred relationship Existential restriction modifier
Ponatinib 30mg tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Ponatinib 30mg tablets Has specific active ingredient Ponatinib hydrochloride true Inferred relationship Existential restriction modifier
Ponatinib 30mg tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ponatinib 30mg tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Ponatinib 30mg tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ponatinib true Inferred relationship Existential restriction modifier
Ponatinib 30mg tablets Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Iclusig 30mg tablets (Incyte Biosciences UK Ltd) Is a True Ponatinib 30mg tablets Inferred relationship Existential restriction modifier
Ponatinib 30mg tablets 30 tablet Has VMP True Ponatinib 30mg tablets Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start